Art. 38 Regulation (EU) 2016/161

Data protection and data ownership

In forcesince 2 Oct 2015cited 1×
1.

Manufacturers, marketing authorisation holders, wholesalers and persons authorised or entitled to supply medicinal products to the public shall be responsible for any data generated when they interact with the repositories system and stored in the audit trail. They shall only have ownership of and access to those data, with the exception of the information referred to in Article 33(2) and the information on the status of a unique identifier.

2.

The legal entity managing the repository where the audit trail is stored shall not access the audit trail and the data contained therein without the written agreement of the legitimate data owners except for the purpose of investigating potential incidents of falsification flagged in the system in accordance with Article 36(b).

  • Judgment of the Court (Seventh Chamber) of 26 January 2023. Consejo General de Colegios Oficiales de Farmacéuticos de España (CGCOF) v AdminDecision

    Thus, for the purpose of introducing security features, Articles 31 to 39 of Delegated Regulation 2016/161 establish rules relating to the repositories system which must contain the information relevant to the use of those safety features.

    26 Jan 2023 · 62021CJ0469